Skip to content

BDD-NET: The German version of an online-based therapy progam for body dysmorphic disorder (BDD)

BDD-NET: The German version of an online-based therapy progam for body dysmorphic disorder (BDD) - BDD-NET: Adaptation for the German language

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00021726
Enrollment
60
Registered
2020-09-16
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F45.2

Interventions

Group 1: experimental group, 12 weeks CBT (Cognitive Behavioral Therapy) program Group 2: waitlist

Sponsors

AE Klinische Psychologie und Psychotherapie Institut für Psychologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) score of = 20 for the BDD-YBOCS (2) primary diagnosis of BDD according to DSM-5 (3) between 18 and 65 years old (4) access to the Internet via a computer (5) Internet literacy

Exclusion criteria

Exclusion criteria: (1) current psychotherapeutical treatment (2) psychotherapeutical treatment in the last 6 months prior to entering the study (3) current substance use disorders (4) current or past bipolar disorder or psychotic disorder (5) current suicidality or self-harm according to DSISS = 3 (Joiner, Pfaff, & Acres, 2002) (6) changes in psychopharmaceutical medication over the last 12 weeks

Design outcomes

Primary

MeasureTime frame
The severity of body dysmorphic disorder symptoms serves as primary outcome. Symptom severity will, among others, be measures using the German version of the BDD-YBOCS (Stangier et al., 2000) and the German version of the Brown Assessment of Belief Scale (Buhlmann, 2014).

Secondary

MeasureTime frame
Mid-Treatment Assessment: after two encounters between therapist and client: STA-R; after 6 weeks: Instruments: FKS, EQ-5D, DASS-21, SESS-R, PMH, CEQ | Post-Assessment after 12 weeks: Instruments: question regarding other treatments during BDD-NET, EQ-5D, DASS-21, PMH, FKS, SSES-R, Client Satisfaction Questionnaire (ZUF-8), STA-R, Videointerviews: BABS, BDD-YBOCS, SCID Module for BDD, Clinical Ratings: CGI- Severity & Improvement | Follow-up Assessment after 4 weeks: Instruments: question regarding other treatments during BDD-NET, EQ-5D, DASS-21, PMH, FKS, SSES-R, Client Satisfaction Questionnaire (ZUF-8), STA-R, Videointerviews: BABS, BDD-YBOCS, SCID for BDD, Clinical Rating: CGI- Severity and Improvement Moreover, we will assess symptom dynamics via smartphones pre and post treatment over the course of four days at each assessment point (ecological momentary assessment). Our hypotheses are preregistered on OSF: https://osf.io/gy5kc/

Countries

Germany

Contacts

Public ContactMarieke Meier

AE Klinische Psychologie und Psychotherapie Institut für Psychologie

marieke.meier@uni-muenster.de0049 251 83 34194

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026